Copper-boosting compounds: A novel concept for antimycobacterial drug discovery

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 2, 2013, Pages 1089-1091

  Speer, Alexandr ^a   Shrestha, Tej B ^b   Bossmann, Stefan H ^b   Basaraba, Randall J ^c   Harber, Gregory J ^c   Michalek, Suzanne M ^d   Niederweis, Michael ^a   Kutsch, Olaf ^d   Wolschendorf, Frank ^d  

^a University of Alabama at Birmingham   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; COPPER ION; DIACETYLBIS[N(4) METHYL 3 THIOSEMICARBAZONE]; GLYOXALBIS[N(4) METHYL 3 THIOSEMICARBAZONE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CHELATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; DRUG TOLERABILITY; HIGH THROUGHPUT SCREENING; IC 50; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; COPPER; DRUG DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENANTHROLINES; TRACE ELEMENTS; TUBERCULOSIS; VIRULENCE FACTORS;

EID: 84872864885     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01781-12     Document Type: Article

References (21)

1. White C, Lee J, Kambe T, Fritsche K, Petris MJ. 2009. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J. Biol. Chem. 284:33949-33956.
2. Ward SK, Abomoelak B, Hoye EA, Steinberg H, Talaat AM. 2010. CtpV: A putative copper exporter required for full virulence of Mycobacterium tuberculosis. Mol. Microbiol. 77:1096-1110.
3. Wolschendorf F, Ackart D, Shrestha TB, Hascall-Dove L, Nolan S, Lamichhane G, Wang Y, Bossmann SH, Basaraba RJ, Niederweis M. 2011. Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 108:1621-1626.
4. Weber FJ, van Berkel WJ, Hartmans S, de Bont JA. 1992. Purification and properties of the NADH reductase component of alkene monooxygenase from Mycobacterium strain E3. J. Bacteriol. 174:3275-3281.
5. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. 2007. Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87: 1011-1046.
6. Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, Chen M, Kim J, Porcelli SA, Chan J, Morris SL, Jacobs WR, Jr. 2006. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24: 6309-6320.
7. Primm TP, Franzblau SG. 2007. Recent advances in methodologies for the discovery of antimycobacterial drugs. Curr. Bioact. Comp. 3:201-208.
8. Danilchanka O, Mailaender C, Niederweis M. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:2503-2511.
9. Ananthan S, Faaleolea ER, Goldman RC, Hobrath JV, Kwong CD, Laughon BE, Maddry JA, Mehta A, Rasmussen L, Reynolds RC, Secrist JA, III, Shindo N, Showe DN, Sosa MI, Suling WJ, White EL. 2009. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb.) 89:334-353.
10. Chen SH, Lin JK, Liu SH, Liang YC, Lin-Shiau SY. 2008. Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol. Sci. 102:138-149.
11. Iversen P, Beck B, Chen YF, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Iversen PW, Montrose C, Moore RA, Weidner Jr. 2004. HTS assay validation. In Sittampalam GS, Gal-Edd N, Arkin M, Auld D, Austin C, Bejcek B, Glicksman M, Inglese J, Lemmon V, Li Z, McGee J, McManus O, Minor L, Napper A, Riss T, Trask OJ, Jr, Weidner J (ed), Assay guidance manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD.
12. Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. 1997. Copper-62-ATSM: A new hypoxia imaging agent with high membrane permeability and low redox potential. J. Nucl. Med. 38: 1155-1160.
13. Lewis J, Laforest R, Buettner T, Song S, Fujibayashi Y, Connett J, Welch M. 2001. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy. Proc. Natl. Acad. Sci. U. S. A. 98:1206-1211.
14. Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, White AR, Crouch PJ, Lim S, Leong SL, Wilkins S, George J, Roberts BR, Pham CL, Liu X, Chiu FC, Shackleford DM, Powell AK, Masters CL, Bush AI, O'Keefe G, Culvenor JG, Cappai R, Cherny RA, Donnelly PS, Hill AF, Finkelstein DI, Barnham KJ. 2012. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. J. Exp. Med. 209:837-854.
15. Soon CP, Donnelly PS, Turner BJ, Hung LW, Crouch PJ, Sherratt NA, Tan JL, Lim NK, Lam L, Bica L, Lim S, Hickey JL, Morizzi J, Powell A, Finkelstein DI, Culvenor JG, Masters CL, Duce J, White AR, Barnham KJ, Li QX. 2011. Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J. Biol. Chem. 286:44035-44044.
16. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731.
17. Kositwattanarerk A, Oh M, Kudo T, Kiyono Y, Mori T, Kimura Y, Maruyama R, Fujibayashi Y, Fujieda S, Okazawa H. 2012. Different distribution of (62)Cu ATSM and (18)F-FDG in head and neck cancers. Clin. Nucl. Med. 37:252-257.
18. Zhang P, Katz J, Michalek SM. 2009. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol. Immunol. 46:677-687.
19. Schmitt SM, Frezza M, Dou QP. 2012. New applications of old metalbinding drugs in the treatment of human cancer. Front. Biosci. (Schol. Ed.) 4:375-391.
20. Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot JP, Guichet PO, Bian X, Armesilla AL, Darling JL, Wang W. 2012. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br. J. Cancer 107:1488-1497.
21. Doyon G, Zerbato J, Mellors JW, Sluis-Cremer N. 2013. Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog (PTEN). AIDS 27:F7-F11.